Search research articles
Contact Us
Filters
Showing results (11-20 of 333) with videos related to
Page
of 34
Sort By:
Innovations in Pharmacy
|
August 29, 2022
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
Paul C Langley
Clinical Therapeutics
|
May 1, 1994
Outcomes research and modeling therapeutic interventions for economic evaluations
P C Langley
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 5, 2002
Modeling for health care and other policy decisions: uses, roles, and validity
Paul C Langley
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Criteria for the economic evaluation of lipid studies in health systems
P C Langley
Innovations in Pharmacy
|
May 23, 2022
Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic Review
Paul C Langley
Innovations in Pharmacy
|
November 30, 2023
Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER'S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms
Paul C Langley
Evolutionary Human Sciences
|
August 17, 2023
Space to play: identifying children's sites in the Pleistocene archaeological record
Michelle C Langley
Current Medical Research and Opinion
|
January 4, 2011
The prevalence, correlates and treatment of pain in the European Union
P C Langley
Clinical Therapeutics
|
January 28, 1998
Modeling the lifetime costs of treating schizophrenia in Australia
C Langley-Hawthorne
Clinical Therapeutics
|
July 1, 1997
The future of pharmacoeconomics: a commentary
P C Langley
Page
of 34
Search research articles
Search
Showing results (11-20 of 333) with videos related to
Sort By:
Page
of 34
Innovations in Pharmacy
|
August 29, 2022
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
Paul C Langley
Clinical Therapeutics
|
May 1, 1994
Outcomes research and modeling therapeutic interventions for economic evaluations
P C Langley
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 5, 2002
Modeling for health care and other policy decisions: uses, roles, and validity
Paul C Langley
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Criteria for the economic evaluation of lipid studies in health systems
P C Langley
Innovations in Pharmacy
|
May 23, 2022
Supping with the Devil: Belief and the Imaginary World of Multiple Myeloma Therapies Invented by the Institute for Clinical and Economic Review
Paul C Langley
Innovations in Pharmacy
|
November 30, 2023
Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER'S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms
Paul C Langley
Evolutionary Human Sciences
|
August 17, 2023
Space to play: identifying children's sites in the Pleistocene archaeological record
Michelle C Langley
Current Medical Research and Opinion
|
January 4, 2011
The prevalence, correlates and treatment of pain in the European Union
P C Langley
Clinical Therapeutics
|
January 28, 1998
Modeling the lifetime costs of treating schizophrenia in Australia
C Langley-Hawthorne
Clinical Therapeutics
|
July 1, 1997
The future of pharmacoeconomics: a commentary
P C Langley
Page
of 34